Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.

Saved in:
Bibliographic Details
Title: Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Authors: Grünwald V; Clinic for Internal Medicine (Tumour Research) and Clinic for Urology, University Hospital Essen, Hufelandtsr. 55, 45147 Essen, Germany; Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625 Hannover, Germany. Electronic address: viktor.gruenwald@uk-essen.de., Chirovsky D; Merck & Co., Inc., Center for Observational and Real World Evidence, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: diana.chirovsky@merck.com., Cheung WY; University of Calgary, Tom Baker Cancer Centre, Department of Oncology, 2500 University Dr. NW, Calgary, Alberta T2N 1N4, Canada; Cross Cancer Institute, Medical Oncology, Alberta Cancer Foundation, 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada. Electronic address: winson.cheung@ahs.ca., Bertolini F; AOU Policlinico di Modena, Day Hospital Oncologico, Azienda Ospedaliero-Universitaria di Modena, Via del Pozzo, 71, 41124 Modena, Italy. Electronic address: bertolini.federica@policlinico.mo.it., Ahn MJ; Samsung Medical Center, Sungkyunkwan University School of Medicine Section of Hematology-Oncology, Department of Medicine, 135-710 Seoul, South Korea. Electronic address: silkahn@skku.edu., Yang MH; Taipei Veterans General Hospital, No. 201, Section 2, Shipai Road, Beitou District, Taipei City 11217, Taiwan, Republic of China. Electronic address: mhyang2@vghtpe.gov.tw., Castro G; Instituto de Cancer do Estado de São Paulo, Faculdade de Medicina da USP - Disciplina de Oncologia, Av Dr Arnaldo 251 - 5o andar, São Paulo, SP 01246-000, Brazil. Electronic address: gilberto.cjunior@hsl.org.br., Berrocal A; Hospital General Universitario de Valencia, Servicio de Oncologia Medica, Avda Tres Cruces S, N, 46006 Valencia, Spain. Electronic address: berrocal_alf@gva.es., Sjoquist K; St George Hospital, Cancer Care Centre, 1 Short Street, Kogarah, NSW 2217, Australia; NHMRC Clinical Trials Centre, University of Sydney, ABN 15 211 513 464, Locked Bag 77, Camperdown, NSW 1450, Australia. Electronic address: katrin.sjoquist@ctc.usyd.edu.au., Kuyas H; Kantar Health, 3 Avenue Pierre Masse, 75014 Paris, France. Electronic address: helene.kuyas@kantarhealth.com., Auclair V; Kantar Health, 3 Avenue Pierre Masse, 75014 Paris, France. Electronic address: valerie.auclair@kantarhealth.com., Guillaume X; Kantar Health, 3 Avenue Pierre Masse, 75014 Paris, France. Electronic address: xavier.guillaume@kantarhealth.com., Joo S; Merck & Co., Inc., Center for Observational and Real World Evidence, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: seongjung.joo@merck.com., Shah R; Merck & Co., Inc., Center for Observational and Real World Evidence, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: roshani1130@gmail.com., Harrington K; The Royal Marsden/Institute of Cancer Research NIHR Biomedical Research Centre, 237 Fulham Road, London SW3 6JB, United Kingdom. Electronic address: Kevin.Harrington@icr.ac.uk.
Corporate Authors: GLANCE H&N STUDY Investigators
Source: Oral oncology [Oral Oncol] 2020 Mar; Vol. 102, pp. 104526. Date of Electronic Publication: 2020 Jan 21.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0593
DOI:10.1016/j.oraloncology.2019.104526